期刊文献+

直肠超声引导下的前列腺穿刺活检检出率分析 被引量:1

Analysis on detection rate of transrectal ultrasound-guided prostate biopsy
下载PDF
导出
摘要 目的分析直肠超声引导前列腺穿刺活检中各指标不同水平组的检出率及临床价值。方法选取2009年5月—2016年7月经直肠超声引导下行前列腺穿刺活检并送检病理检查的98例患者进行分析。结果 98例患者中,前列腺癌检出率为29.6%。经过不同的血清前列腺特异抗原(PSA)水平组队下,病理结果差异有统计学意义(P<0.001),穿刺结果阳性率随PSA水平的升高而上升;超声检查结果发现有结节的前列腺癌中,结节位置都位于外腺。结论经直肠超声引导下前列腺穿刺前列腺癌检出率与PSA的水平呈正相关;当发现外腺低回声结节时应警惕为前列腺癌的可能。 Objective To analyze the detection rates of various indicators at different levels following transrectal ultrasound-guided prostate biopsy,and evaluate the clinical value of ultrasound-guided biopsy.Methods Ninety-eight patients who underwent prostate biopsy guided by transtectal ultrasound(TRUS)from May 2009 to July 2016 were analyzed.Results In the ninety-eight patients,the detection rate of prostate cancer was 29.6%.The positive rates of biopsy increased with the rising of prostate specific antigen(PSA)levels(P<0.001).Ultrasound examination revealed nodules in outer glands of the prostate cancer cases.Conclusion The detection rate of prostate cancer is positively correlated with PSA level.Any outer gland hypoechoic nodules should arouse suspicion of prostate cancer.
作者 陈燕君 CHEN Yanjun(Physical Examination Station,Putuo District Central Hospital,Shanghai 200062,China)
出处 《外科研究与新技术》 2017年第4期265-267,共3页 Surgical Research and New Technique
关键词 前列腺特异性抗原 经直肠超声 前列腺癌 前列腺穿刺 Prostate specific antigen Transtectal ultrasound Prostate cancer Prostate biopsy
  • 相关文献

参考文献4

二级参考文献59

  • 1赵耀瑞,徐勇,张殿举,畅继武,张淑敏,史启铎,孙光,韩瑞发,姚庆祥,马腾骧.血清PSA、PSAD和PSAT在前列腺穿刺活检中的意义[J].中华泌尿外科杂志,2005,26(9):622-625. 被引量:35
  • 2Roobol MJ,Kranse R,de Koning HJ,et al.Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer:results of second screening round of ERSPC (ROTTERDAM).Urology,2004,63:309-313.
  • 3Thompson IM,Pauler DK,Goodman PJ,et al.Prevalence of prostate cancer among men with a prostate-specific antigen level < or=4.0 ng per milliliter.N Engl J Med,2004,350:2239-2246.
  • 4Kobayashi T,Nishizawa K,Ogura K,et al.Detection of prostate cancer in men with prostate-specific antigen levels of 2.0 to 4.0 ng/mL equivalent to that in men with 4.1 to 10.0 ng/mL in a Japanese population.Urology,2004,63:727-731.
  • 5Brawe MK.The diagnosis of prostatic carcinoma.Cancer,1993,71(3 Suppl):899-905.
  • 6Kuwahara M,Tochigi T,Kawamura S,et al.Mass screening for prostate cancer:a comparative study in Natori,Japan and Changchun,China.Urology,2003,61:137-141.
  • 7Yu HJ,Chie WC,Hsieh CH,et al.Clinical efficacy of prostate-specific antigen testing in patients with prostatic disease.J Formos Med Assoc,1996,95:782-788.
  • 8Khan MA,Carter HB,Epstein JI,et al.Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer? J Urol,2003,170(6 Pt 1):2274-2278.
  • 9Punglia RS,D′Amico AV,Catalona WJ,et al.Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.N Engl J Med,2003,349:335-342.
  • 10Schroder FH,van der Maas P,Beemsterboer P,et al.Evaluation of the digital rectal examination as a screening test for prostate cancer.Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.J Natl Cancer Inst,1998,90:1817-1823.

共引文献802

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部